San Diego, CA, United States of America

Viking Therapeutics, Inc.


USPTO Granted Patents = 13


Trademarks = 1

Forward Citations = 25

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Brian Lian (13 out of 13 patents)

silverMedal Geoffrey E Barker (9 out of 9 patents)

bronzeMedal Maureen Barnes (5 out of 5 patents)

4.  Kader Yagiz (5 out of 5 patents)

5.  Erland Stevens (5 out of 5 patents)

6.  Hiroko Masamune (4 out of 5 patents)

7.  Rochelle Hanley (3 out of 4 patents)

8.  Misha Dinerman (3 out of 3 patents)

9.  Mark D Erion (3 out of 61 patents)

10.  Serge H Boyer (3 out of 47 patents)

11.  Hongjian Jiang (2 out of 2 patents)

12.  Hongjian Jiang (1 out of 10 patents)


13 patents:

Company Overview
Viking Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on the development of innovative therapies for metabolic and endocrine disorders. The company specializes in advancing novel drug candidates that target key biological pathways to improve patient outcomes. With a commitment to scientific excellence, Viking Therapeutics aims to address significant unmet medical needs through its research and development efforts in the biopharmaceutical sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#410 in San Diego, CA

#5,650 in California

#23,815 in US

#44,988 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 25

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viking Therapeutics, Inc.. Retrieved from https://idiyas.com/company/viking-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…